reported a male MM patient with CNS myeloma who was successfully treated with Elranatamab, a humanized bispecific antibody targeting B-cell maturation antigen (BCMA) and CD3-expressing T cells (26). The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.